Search
for
Sort by
Research 31–60 of 1000+
- The Clinical Differences on 2:4 Finger Ratios of the Hirsute Women
- Endocrine control of benign prostatic hyperplasia
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Gender aspects in skin diseases
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- PCOS and Obesity: Contraception Challenges
- New onset of alopecia in a young woman with end-stage renal disease
- Steroid Hormones of Reproduction and Sexual Development
- Endocrinology of Transgender Medicine
- Gender differences in skin: A review of the literature
- Gender Differences in Cardiac Hypertrophy
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- STEROID HORMONES IN GERIATRICS
- The Neurobiology of Sexual Function
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- Is dehydroepiandrosterone a hormone?
- Sex Steroid Hormone Receptors in Human Skin Appendage and its Neoplasms
- Sulfatase inhibitors: a patent review
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- In Vitro Main Pathways of Steroid Action in Cultured Hair Follicle Cells: Vascular Approach
- 25 years of ERβ: a personal journey
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Effect of 5α-Dihydrotestosterone and Testosterone on Apoptosis in Human Dermal Papilla Cells
- Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha
- Approach to the adult female patient with diffuse nonscarring alopecia
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders